OPDIVO (Nivolumab, Ono and Bristol) and KEYTRUDA (Pembrolizumab, MSD) are anticancer drugs containing anti-PD-1 antibody as an active ingredient. In 2019,...
Article list
Editor
Daisuke Tokushige
I work for a Japanese IP law firm called SK Intellectual Property Law Firm. My work includes preparing patent specification, response to office action, patent search, and advising a company on patent issues.
Category